- Documento2019-11-11 - MN Insulin Action - Motion Dismiss Dfds Responseenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoIn Re EpiPen MDL - T1DF Seeks Filing of Expert Reportsenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoIn RE EPIPEN - Humana - Order on Costs - 2019-02-04enviado porThe Type 1 Diabetes Defense Foundation
- DocumentoIn RE EPIPEN MARKETING - Plaintiffs' Opposition to Humana Motion 2018-07-11enviado porThe Type 1 Diabetes Defense Foundation
- DocumentoIn Re EpiPen - Mylan Defendants' Opposition to Class Certification 2019-06-18enviado porThe Type 1 Diabetes Defense Foundation
- DocumentoMN AG v. SANOFI - 3:18-cv-14999 - Defendants' Joint Motion to Dismiss - 2019-08-12enviado porThe Type 1 Diabetes Defense Foundation
- Documento2019-08-07 - KY OAG - PRR1 - Denialenviado porThe Type 1 Diabetes Defense Foundation
- Documento2019-07-31 - Public Record Request to Kentucky AG re Insulin Pricingenviado porThe Type 1 Diabetes Defense Foundation
- Documento2019-07-31 - Public Record Request to Minnesota AG re Insulin Pricingenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF Financial Report - 2019enviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF filed FOIA request re intranasal Glucagon 2019-07-31enviado porThe Type 1 Diabetes Defense Foundation
- Documento2019-06-28 - T1DF - EpiPen MDL - Phase 2 Hearing Presentationenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF Letter to EpiPen MDL Judge Crabtree re Intra Class Conflictsenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF Statement in Support of Oregon Insulin Emergency Refill Bill SB 9A - 2019-04-16enviado porThe Type 1 Diabetes Defense Foundation
- Documento2019-02-15 - In Re Insulin Pricing Litigation - Opinion on Motion to Dismissenviado porThe Type 1 Diabetes Defense Foundation
- Documento2019-01-07 - 18023 - Boss v CVS - Dismissal Order and Exhibit Aenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoIn re Insulin Pricing Litigation -- Tolling and Standstill Agreement Dated 2018-01-26enviado porThe Type 1 Diabetes Defense Foundation
- DocumentoBoss v. CVS Health - Notice of Voluntary Dismissalenviado porThe Type 1 Diabetes Defense Foundation
- Documento2017-09-18 in Re Insulin Opinion Interim Leadershipenviado porThe Type 1 Diabetes Defense Foundation
- Documento2018-11-07 Order - Boss v. CVS insulin action unconsolidatedenviado porThe Type 1 Diabetes Defense Foundation
- Documento20118-11-06 - Letter to MN AG - T1DF-Boss - Breaches of MN RPCenviado porThe Type 1 Diabetes Defense Foundation
- Documento2018-08-23enviado porThe Type 1 Diabetes Defense Foundation
- Documento2018-08-1 - Insulin Litigation - DE 17-699 Final Order - Julia Boss Papersenviado porThe Type 1 Diabetes Defense Foundation
- Documento2018-07-31 - Securities Case 00209 - De 97 - Dfdts Perrigo Noticeenviado porThe Type 1 Diabetes Defense Foundation
- Documento2018-08-01 - Securities Case 00209 - DE 98 - NVO Response to Perrigoenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF Financial Report - FY Ending 2018enviado porThe Type 1 Diabetes Defense Foundation
- DocumentoInsulin Pricing Litigation - First Amended Class Action Complaint - April 2018enviado porThe Type 1 Diabetes Defense Foundation
- DocumentoOrder transferring Bentele v. Eli Lilly back to New Jersey District Courtenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF PBM IBM Payer Manufacturer Map 2017.03.01enviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF - Course of Action Renegotiation With Hagens Bermanenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoInsulin Action - T1DF October 2017 Memo - Review of HB Consolidated Complaintenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF letter to OR Gov. Kate Brownenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF Comment to Oregon Task Force on Fair Pricing - May 19 2018enviado porThe Type 1 Diabetes Defense Foundation
- DocumentoInsulin Action - JB Response to HB Opp - Motion for Reconsiderationenviado porThe Type 1 Diabetes Defense Foundation
- Documento2018-04-12 - In re Insulin Pricing Litigation - JB Judicial Notice - Misrepresentationenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF - Brown Drug Pricing Transparency - 2018-03-26enviado porThe Type 1 Diabetes Defense Foundation
- Documento2018-03-26 - Ltr BOSS-T1DF - Appeal Lehigh County 2018-03-23 Responseenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF - Inquiry Re CO HB18-1009enviado porThe Type 1 Diabetes Defense Foundation
- DocumentoLehigh County - Response to RTK Request for proof of authorization to sue Novo Nordiskenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoTranscript of Proceedings in In re National Prescription Opiate Litigationenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoOpioid MDL - Leter From J. Cicala to Hon. Dan a. Polsterenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoOpinion Granting Motion Dimiss in In re Express Scripts-Anthem ERISA Litigationenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF Motion Reconsideration Consolidation - Insulin action Dckt 119enviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF - Request Drug Pricing Records No-2 - OPDP OHA - 2018-03-14enviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF - Request For Drug Pricing Records From OPDP OHA - 2018-03-13enviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF 2018-03-02 - Petition for Reconsideration of Appeal to OOR AP 2018-0378enviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF Letter to Oregon Governor Kate Brown Re - HB 4005enviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF 2018-02-28 Appeal to OORenviado porThe Type 1 Diabetes Defense Foundation
- DocumentoT1DF Comments on Medicare Part D Proposed Rule on Access to Negotiated Priceenviado porThe Type 1 Diabetes Defense Foundation